Nuvation Bio Inc. financial data

Symbol
NUVB, NUVB-WT on NYSE
Location
357 Tehama Street, Floor 3, San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 897 % -47.2%
Quick Ratio 2.56 %
Debt-to-equity 44.2 % +419%
Return On Equity -55 % +49.4%
Return On Assets -38.1 % +57%
Operating Margin -871 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 343M shares +1.86%
Common Stock, Shares, Outstanding 338M shares +0.47%
Entity Public Float 523B USD +100%
Common Stock, Value, Issued 1.4B USD +3.1%
Weighted Average Number of Shares Outstanding, Basic 342K shares +25.2%
Weighted Average Number of Shares Outstanding, Diluted 342K shares +25.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 13.1M USD +1705%
Revenue from Contract with Customer, Excluding Assessed Tax 26.7M USD +1705%
Research and Development Expense 110M USD +29.3%
General and Administrative Expense 28.2M USD -12.5%
Operating Income (Loss) -233M USD +58.4%
Nonoperating Income (Expense) 15.5M USD -43.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -217M USD +59.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -217M USD +59.1%
Earnings Per Share, Basic 0 USD/shares +77.5%
Earnings Per Share, Diluted 0 USD/shares +77.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 98.9M USD +229%
Marketable Securities, Current 450M USD -13.3%
Inventory, Net 5.71M USD
Assets, Current 578M USD +2.22%
Property, Plant and Equipment, Net 560K USD -22.1%
Operating Lease, Right-of-Use Asset 4.33M USD +75.1%
Other Assets, Noncurrent 7.46M USD +1455%
Assets 602M USD +5.25%
Accounts Payable, Current 15.4M USD +24.1%
Accrued Liabilities, Current 32.6M USD +38.6%
Contract with Customer, Liability, Current 6.72M USD -48.1%
Liabilities, Current 68.1M USD +15.4%
Contract with Customer, Liability, Noncurrent 13.6M USD
Accrued Income Taxes, Noncurrent 679K USD +372%
Operating Lease, Liability, Noncurrent 2.97M USD +202%
Liabilities 276M USD +300%
Common Stocks, Including Additional Paid in Capital 117M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -139K USD -110%
Retained Earnings (Accumulated Deficit) -1.08B USD -25.3%
Stockholders' Equity Attributable to Parent 326M USD -35.2%
Liabilities and Equity 602M USD +5.25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -42.6M USD -171%
Net Cash Provided by (Used in) Financing Activities 548K USD +2510%
Net Cash Provided by (Used in) Investing Activities 54.2M USD +618%
Common Stock, Shares Authorized 1.06B shares
Common Stock, Shares, Issued 343M shares +1.94%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 98.9M USD +229%
Deferred Tax Assets, Valuation Allowance 238M USD +137%
Deferred Tax Assets, Gross 243M USD +139%
Operating Lease, Liability 4.84M USD +75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -219M USD +58.5%
Lessee, Operating Lease, Liability, to be Paid 5.5M USD +87.9%
Property, Plant and Equipment, Gross 1.46M USD +5.57%
Operating Lease, Liability, Current 1.87M USD +5.05%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.18M USD +45.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 533K USD -6.66%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +402%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 656K USD +313%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.4M USD +96.9%
Deferred Tax Assets, Operating Loss Carryforwards 108M USD +268%
Unrecognized Tax Benefits 7.39M USD +31.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.22M USD +744%
Share-based Payment Arrangement, Expense 38.1M USD +47.6%
Interest Expense 5.12M USD